Is There Still a Role for Glycoprotein IIb/IIIa Antagonists in Acute Coronary Syndromes?

por Iannetta, Loredana, Puddu, Paolo Emilio, Cuturello, Domenico, Saladini, Angela, Pellicano, Mariano, Schiariti, Michele
Publicado 2013

GPIIb/IIIa Receptor Antagonism Using Small Molecules Provides no Additive Long-Term Protection after Percutaneous Coronary Intervention as Compared to Clopidogrel Plus Aspirin

por Schiariti, Michele, Saladini, Angela, Papalia, Francesco, Grillo, Placido, Nesta, Cristina, Cuturello, Domenico, Missiroli, Bindo, Puddu, Paolo Emilio
Publicado 2010